Varying outcomes of triple-negative breast cancer in different age groups–prognostic value of clinical features and proliferation

WHO Classification of Tumours Editorial Board (2019) Breast tumours. WHO classification of tumors series, vol 2, 5th edn. International Agency for Research on Cancer, Lyon

Google Scholar 

Lyons TG (2019) Targeted therapies for triple-negative breast cancer. Curr Treat Options Oncol 20(11):82. https://doi.org/10.1007/s11864-019-0682-x

Article  PubMed  Google Scholar 

Zhao S, Ma D, Xiao Y, Li XM, Ma JL, Zhang H et al (2020) Molecular subtyping of triple-negative breast cancers by immunohistochemistry: molecular basis and clinical relevance. Oncologist 25(10):e1481–e1491. https://doi.org/10.1634/theoncologist.2019-0982

Article  CAS  PubMed  PubMed Central  Google Scholar 

Curigliano G, Burstein HJ, Winer EP, Gnant M, Dubsky P, Loibl S et al (2018) De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International expert consensus conference on the primary therapy of early breast cancer 2017. Ann Oncol 28(8):1700–1712. https://doi.org/10.1093/annonc/mdx308

Article  Google Scholar 

Wenzel ES, Singh ATK (2018) Cell-cycle checkpoints and aneuploidy on the path to cancer. In Vivo 32(1):1–5. https://doi.org/10.21873/invivo.11197

Article  CAS  PubMed  PubMed Central  Google Scholar 

Loibl S, Poortmans P, Morrow M, Denkert C, Curigliano G (2021) Breast cancer. Lancet 397(10286):1750–1769. https://doi.org/10.1016/S0140-6736(20)32381-3

Article  CAS  PubMed  Google Scholar 

Arafah MA, Ouban A, Ameer OZ, Quek KJ (2021) Ki-67 LI expression in triple-negative breast cancer patients and its significance. Breast Cancer (Auckl) 15:11782234211016976. https://doi.org/10.1177/11782234211016977

Article  Google Scholar 

Keam B, Im SA, Lee KH, Han SW, Oh DY, Kim JH et al (2011) Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis. Breast Cancer Res 13(2):R22. https://doi.org/10.1186/bcr2834

Article  PubMed  PubMed Central  Google Scholar 

Wang RX, Chen S, Jin X, Shao ZM (2016) Value of Ki-67 expression in triple-negative breast cancer before and after neoadjuvant chemotherapy with weekly paclitaxel plus carboplatin. Sci Rep 6:30091. https://doi.org/10.1038/srep30091

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nishimura R, Osako T, Okumura Y, Hayashi M, Arima N (2010) Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis. Breast Cancer 17:269–275. https://doi.org/10.1007/s12282-009-0161-5

Article  PubMed  Google Scholar 

Zhu X, Chen L, Huang B, Wang Y, Ji L, Wu J et al (2020) The prognostic and predictive potential of Ki-67 in triple-negative breast cancer. Sci Rep 10(1):225. https://doi.org/10.1038/s41598-019-57094-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miyashita M, Ishida T, Ishida K, Tamaki K, Amari M, Watanabe M et al (2011) Histopathological subclassification of triple negative breast cancer using prognostic scoring system: five variables as candidates. Virchows Arch 458(1):65–72. https://doi.org/10.1007/s00428-010-1009-2

Article  PubMed  Google Scholar 

Munzone E, Botteri E, Sciandivasci A, Curigliano G, Nolè F, Mastropasqua M et al (2012) Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer. Breast Cancer Res Treat 134(1):277–282. https://doi.org/10.1007/s10549-012-2040-6

Article  PubMed  Google Scholar 

Røge R, Nielsen S, Riber-Hansen R, Vyberg M (2021) Ki-67 proliferation index in breast cancer as a function of assessment method: a NordiQC experience. Appl Immunohistochem Mol Morphol 29(2):99–104. https://doi.org/10.1097/PAI.0000000000000846

Article  CAS  PubMed  Google Scholar 

Sun X, Kaufman PD (2018) Ki-67: more than a proliferation marker. Chromosoma 127(2):175–186. https://doi.org/10.1007/s00412-018-0659-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matthews HK, Bertoli C, de Bruin RAM (2022) Cell cycle control in cancer. Nat Rev Mol Cell Biol 23(1):74–88. https://doi.org/10.1038/s41580-021-00404-3

Article  CAS  PubMed  Google Scholar 

Risteski P, Jagrić M, Pavin N, Tolić IM (2021) Biomechanics of chromosome alignment at the spindle midplane. Curr Biol 31(10):R574–R585. https://doi.org/10.1016/j.cub.2021.03.082

Article  CAS  PubMed  Google Scholar 

Potapova T, Gorbsky GJ (2017) The consequences of chromosome segregation errors in mitosis and meiosis. Biology (Basel) 6(1):12. https://doi.org/10.3390/biology6010012

Article  CAS  Google Scholar 

Burstein HJ, Curigliano G, Thürlimann B, Weber WP, Poortmans P, Regan MM et al (2021) Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International consensus guidelines for treatment of early breast cancer 2021. Ann Oncol 32(10):1216–1235. https://doi.org/10.1016/j.annonc.2021.06.023

Article  CAS  PubMed  Google Scholar 

Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Thürlimann B, Senn HJ (2009) Thresholds for therapies: highlights of the St Gallen International expert consensus on the primary therapy of early breast cancer. Ann Oncol 20:1319–1329. https://doi.org/10.1093/annonc/mdp322

Article  CAS  PubMed  PubMed Central  Google Scholar 

Botti G, Cantile M, Collina F, Cerrone M, Sarno S, Anniciello A (2019) Morphological and pathological features of basal-like breast cancer. Transl Cancer Res 8(Suppl 5):S503–S509. https://doi.org/10.21037/tcr.2019.06.50

Article  CAS  PubMed  PubMed Central  Google Scholar 

Repo H, Löyttyniemi E, Nykänen M, Lintunen M, Karra H, Pitkänen R et al (2016) The expression of cohesin subunit SA2 predicts breast cancer survival. Appl Immunohistochem Mol Morphol 24(9):615–621. https://doi.org/10.1097/PAI.0000000000000240

Article  CAS  PubMed  Google Scholar 

Tuominen VJ, Ruotoistenmäki S, Viitanen A, Jumppanen M, Isola J (2010) ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67. Breast Cancer Res 12(4):R56. https://doi.org/10.1186/bcr2615

Article  PubMed  PubMed Central  Google Scholar 

Therneau T (2022) A package for survival analysis in R. R package version 3.3–1. https://CRAN.R-project.org/package=survival.

Kassambara A, Kosinski M, Biece P, Scheipl F (2021) Drawing survival curves using 'ggplot2'. R package version 0.4.9. https://mran.revolutionanalytics.com/package/survminer

Dai D, Zhong Y, Wang Z, Yousafzai NA, Jin H, Wang X et al (2019) The prognostic impact of age in different molecular subtypes of breast cancer: a population-based study. PeerJ 7:e7252. https://doi.org/10.7717/peerj.7252

Article  PubMed  PubMed Central  Google Scholar 

Johansson ALV, Trewin CB, Hjerkind KV, Ellingjord-Dale M, Johannesen TB, Ursin G et al (2019) Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort. Int J Cancer 144(6):1251–1261. https://doi.org/10.1002/ijc.31950

Article  CAS  PubMed  Google Scholar 

Chen HL, Zhou MQ, Tian W, Meng KX, He HF (2016) Effect of age on breast cancer patient prognoses: a population-based study using the SEER 18 database. PLoS ONE 11(10):e0165409. https://doi.org/10.1371/journal.pone.0165409

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alabdulkareem H, Pinchinat T, Khan S, Landers A, Christos P, Simmons R et al (2018) The impact of molecular subtype on breast cancer recurrence in young women treated with contemporary adjuvant therapy. Breast J 24(2):148–153. https://doi.org/10.1111/tbj.12853

Article  CAS  PubMed  Google Scholar 

Chung WP, Lee KT, Chen YP, Hsu YT, Loh ZJ, Huang CC et al (2021) The prognosis of early-stage breast cancer in extremely young female patients. Medicine (Baltimore) 100(1):e24076. https://doi.org/10.1097/MD.0000000000024076

Article  Google Scholar 

Liu Y, Xin T, Huang DY, Shen WX, Li L, Lv YJ et al (2014) Prognosis in very young women with triple-negative breast cancer: retrospective study of 216 cases. Med Oncol 31(12):222. https://doi.org/10.1007/s12032-014-0222-2

Article  PubMed  Google Scholar 

Aine M, Boyaci C, Hartman J, Häkkinen J, Mitra S, Campos AB et al (2021) Molecular analyses of triple-negative breast cancer in the young and elderly. Breast Cancer Res 23(1):20. https://doi.org/10.1186/s13058-021-01392-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lian W, Fu F, Lin Y, Lu M, Chen B, Yang P et al (2017) The impact of young age for prognosis by subtype in women with early breast cancer. Sci Rep 7(1):11625. https://doi.org/10.1038/s41598-017-10414-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fallahpour S, Navaneelan T, De P, Borgo A (2017) Breast cancer survival by molecular subtype: a population-based analysis of cancer registry data. CMAJ Open 5(3):E734–E739. https://doi.org/10.9778/cmajo.20170030

Article  PubMed  PubMed Central  Google Scholar 

Fredholm H, Magnusson K, Lindström LS, Garmo H, Fält SE, Lindman H et al (2016) Long-term outcome in young women with breast cancer: a population-based study. Breast Cancer Res Treat 160(1):131–143. https://doi.org/10.1007/s10549-016-3983-9

Article  PubMed  PubMed Central  Google Scholar 

Chollet-Hinton L, Anders CK, Tse CK, Bell MB, Yang YC, Carey LA et al (2016) Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina breast cancer study: a case-control study. Breast Cancer Res 18(1):79. https://doi.org/10.1186/s13058-016-0736-y

Article  PubMed  PubMed Central  Google Scholar 

Tzikas AK, Nemes S, Linderholm BK (2020) A comparison between young and old patients with triple-negative breast cancer: biology, survival and metastatic patterns. Breast Cancer Res Treat 182(3):643–654. https://doi.org/10.1007/s10549-020-05727-x

留言 (0)

沒有登入
gif